| 351 |
17890152 | Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. | 2007 Oct |
1 |
| 352 |
17917501 | Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy. | 2007 Oct |
1 |
| 353 |
17945530 | Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. | 2007 Nov |
1 |
| 354 |
17956203 | Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives. | 2007 Nov |
2 |
| 355 |
17970614 | Direct renin inhibition: focus on aliskiren. | 2007 Oct |
3 |
| 356 |
17992567 | Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. | 2007 Dec |
1 |
| 357 |
17999872 | Aliskiren: the first direct renin inhibitor for hypertension. | 2007 Nov |
2 |
| 358 |
18058456 | Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension. | 2007 |
2 |
| 359 |
18090068 | Aliskiren: an oral renin inhibitor for the treatment of hypertension. | 2007 Nov-Dec |
3 |
| 360 |
18174970 | Aliskiren. | 2007 Dec |
2 |
| 361 |
18200801 | Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension. | 2007 |
3 |
| 362 |
18205098 | Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. | 2007 Dec |
2 |
| 363 |
20409858 | Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis. | 2007 Jul-Aug |
2 |
| 364 |
16467656 | Conformational changes in prorenin during renin inhibition in vitro and in vivo. | 2006 Mar |
3 |
| 365 |
16508564 | Renin inhibition with aliskiren: where are we now, and where are we going? | 2006 Feb |
2 |
| 366 |
16776501 | Formal total synthesis of the potent renin inhibitor aliskiren: application of a SmI2-promoted acyl-like radical coupling. | 2006 Jun 23 |
2 |
| 367 |
16914963 | Renin inhibition. | 2006 Sep |
2 |
| 368 |
16965731 | New drugs for hypertension: what do they offer? | 2006 Oct |
2 |
| 369 |
16979787 | Imaging the renin-angiotensin system: an important target of anti-hypertensive therapy. | 2006 Sep 15 |
1 |
| 370 |
16989601 | Aliskiren: a renin inhibitor offering a new approach for the treatment of hypertension. | 2006 Oct |
1 |
| 371 |
17025315 | Expanding the scope of the acyl-type radical addition reactions promoted by SmI2. | 2006 Oct 13 |
1 |
| 372 |
17048976 | Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus. | 2006 |
2 |
| 373 |
17055947 | Oral renin inhibitors. | 2006 Oct 21 |
2 |
| 374 |
17073832 | Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. | 2006 Nov |
2 |
| 375 |
17112720 | Opportunities for structure-based design of protease-directed drugs. | 2006 Dec |
1 |
| 376 |
17118124 | Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects. | 2006 Dec |
3 |
| 377 |
17378372 | Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension. | 2006 Dec |
4 |
| 378 |
17699210 | Direct renin inhibition with aliskiren in hypertension and target organ damage. | 2006 Mar |
2 |
| 379 |
18221088 | The renin inhibitor aliskiren as novel treatment for cardiovascular disease. | 2006 Nov |
3 |
| 380 |
15662231 | Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. | 2005 Feb |
3 |
| 381 |
15720221 | The future of angiotensin II inhibition in cardiovascular medicine. | 2005 Feb |
1 |
| 382 |
16103264 | Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. | 2005 Sep |
2 |
| 383 |
16300168 | Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. | 2005 Nov |
1 |
| 384 |
15373937 | Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects. | 2004 Oct |
2 |
| 385 |
15579516 | Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. | 2004 Dec |
4 |
| 386 |
12692747 | Potential of renin inhibition in cardiovascular disease. | 2003 Mar |
1 |
| 387 |
12927775 | Structure-based design of aliskiren, a novel orally effective renin inhibitor. | 2003 Sep 5 |
6 |
| 388 |
14597641 | Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. | 2003 Dec |
3 |
| 389 |
14728059 | Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. | 2003 |
1 |
| 390 |
11799102 | Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. | 2002 Jan |
8 |
| 391 |
12168611 | Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100). Comparison with enalapril. | 2002 Aug |
2 |